Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.

CSE:RVV - Post by User

Revive Therapeutics Ltd. > My level 2 site is down.

<< Previous

Bullboard Posts

Next >>

Comment by Imarunawayon Dec 08, 2020 10:40am

65 Views

Post# 32057436

RE:My level 2 site is down.

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
39,000 shares	39,000	0.440
70,500 shares	70,500	0.435
127,000 shares	127,000	0.430
23,500 shares	23,500	0.425
71,500 shares	71,500	0.420
23,000 shares	23,000	0.415
29,500 shares	29,500	0.410
31,000 shares	31,000	0.405
330,000 shares	330,000	0.400
6,000 shares	6,000	0.395

Level two quotes - Ask
Ask Price	Number of Shares
0.450	431,000	431,000 shares
0.455	210,500	210,500 shares
0.460	260,000	260,000 shares
0.465	25,500	25,500 shares
0.470	25,000	25,000 shares
0.475	14,500	14,500 shares
0.480	86,000	86,000 shares
0.485	2,500	2,500 shares
0.490	52,000	52,000 shares
0.495	21,000